BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33947521)

  • 1. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study.
    Kondo T; Sassa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathology; 2021 Oct; 53(6):720-727. PubMed ID: 33947521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.
    Kondo T; Sasa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathol Int; 2018 Oct; 68(10):543-549. PubMed ID: 30187581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.
    Nouh MA; Kuroda N; Yamashita M; Hayashida Y; Yano T; Minakuchi J; Taniguchi S; Nomura I; Inui M; Sugimoto M; Kakehi Y
    BJU Int; 2010 Mar; 105(5):620-7. PubMed ID: 19747356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired cystic disease subtype renal cell carcinoma (ACD-RCC): prevalence and imaging features at a single institution.
    Carnahan MB; Kunzelman J; Kawashima A; Patel BN; Menias CO; Fananapazir G
    Abdom Radiol (NY); 2022 Aug; 47(8):2858-2866. PubMed ID: 35674787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
    Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
    Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic characterization of renal epithelial neoplasms arising in nonfunctioning kidneys.
    Lin X; Goyal R; Yang XJ
    Hum Pathol; 2020 Mar; 97():1-7. PubMed ID: 31857138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up.
    Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
    Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease-associated Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic Lesions.
    Kojima F; Gandhi JS; Matsuzaki I; Iba A; Collier S; Yoshikawa T; Kinoshita Y; Warigaya K; Fujimoto M; Kuroda N; Morii E; Hara I; Murata SI; Amin MB
    Am J Surg Pathol; 2020 Aug; 44(8):1031-1039. PubMed ID: 32271189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal tumors in end-stage renal disease: A comprehensive review.
    Tsuzuki T; Iwata H; Murase Y; Takahara T; Ohashi A
    Int J Urol; 2018 Sep; 25(9):780-786. PubMed ID: 30066367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal cell carcinoma in patients with end-stage renal disease: a clinicopathological analysis].
    He B; Zhang W; Liu LN; Wang H; Zou YW; Jiang YX; Yu WJ; Shi HL; Liu Y; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):846-850. PubMed ID: 31775432
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathologic spectrum of cysts in end-stage kidneys: possible precursors to renal neoplasia.
    Hosseini M; Antic T; Paner GP; Chang A
    Hum Pathol; 2014 Jul; 45(7):1406-13. PubMed ID: 24775605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyst-associated renal cell carcinoma: clinicopathologic characteristics and evaluation of prognosis in 27 cases.
    Onishi T; Oishi Y; Goto H; Tomita M; Abe K; Sugaya S
    Int J Urol; 2001 Jun; 8(6):268-74. PubMed ID: 11389741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
    Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
    Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Cell Carcinoma in End-Stage Renal Disease: A Retrospective Study in Patients from Hungary.
    Semjén D; Dénes B; Somorácz Á; Fintha A; Forika G; Jenei A; Dobi D; Micsik T; Eizler KV; Giba N; Sánta F; Sejben A; Iványi B; Kuthi L
    Pathobiology; 2023; 90(5):322-332. PubMed ID: 36696889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma.
    Ishihara H; Fukuda H; Tachibana H; Yoshida K; Kobayashi H; Takagi T; Iizuka J; Ishida H; Nagashima Y; Kondo T; Tanabe K
    Clin Exp Nephrol; 2021 Jun; 25(6):674-682. PubMed ID: 33641007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma in patients with end-stage renal disease is associated with more favourable histological features and prognosis.
    Chen K; Huang HH; Aydin H; Tan YH; Lau WK; Cheng CW; Yuen JS
    Scand J Urol; 2015 Jun; 49(3):200-4. PubMed ID: 25783025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.